1. Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo
- Author
-
Renaud Bouzanne des Mazery, Dirk Schepmann, Bernhard Wünsch, Kun-Yuan Lin, Clemens Wagner, Peter Molenveld, Roy P. M. Storcken, Anita Wegert, Dieter Metze, Geert Jan Sterk, Marjon G. Bolster, Michael Soeberdt, Reshma Autar, Chih-Ching Lai, Sonja Ständer, Tai-Yu Huang, Sebastianus N. H. Aerts, Christoph Abels, Giovanni Tangherlini, Tobias Lotts, Bastian Frehland, Ulrich Knie, and Frank R. van Holst
- Subjects
Male ,0301 basic medicine ,Stereochemistry ,medicine.drug_class ,Guinea Pigs ,Anti-Inflammatory Agents ,Dermatitis ,01 natural sciences ,Mice ,03 medical and health sciences ,In vivo ,Opioid receptor ,Quinoxalines ,Drug Discovery ,medicine ,Animals ,Humans ,Rats, Wistar ,Binding site ,Receptor ,Skin ,Mice, Inbred BALB C ,Mice, Inbred ICR ,010405 organic chemistry ,Chemistry ,Receptors, Opioid, kappa ,Combinatorial chemistry ,0104 chemical sciences ,030104 developmental biology ,Opioid ,Drug Design ,Molecular Medicine ,NMDA receptor ,Amine gas treating ,Pharmacophore ,medicine.drug - Abstract
In order to develop novel κ agonists restricted to the periphery, a diastereo- and enantioselective synthesis of (4aR,5S,8aS)-configured decahydroquinoxalines 5-8 was developed. Physicochemical and pharmacological properties were fine-tuned by structural modifications in the arylacetamide and amine part of the pharmacophore as well as in the amine part outside the pharmacophore. The decahydroquinoxalines 5-8 show single-digit nanomolar to subnanomolar κ-opioid receptor affinity, full κ agonistic activity in the [35S]GTPγS assay, and high selectivity over μ, δ, σ1, and σ2 receptors as well as the PCP binding site of the NMDA receptor. Several analogues were selective for the periphery. The anti-inflammatory activity of 5-8 after topical application was investigated in two mouse models of dermatitis. The methanesulfonamide 8a containing the (S)-configured hydroxypyrrolidine ring was identified as a potent (Ki = 0.63 nM) and highly selective κ agonist (EC50 = 1.8 nM) selective for the periphery with dose-dependent anti-inflammatory activity in acute and chronic skin inflammation.
- Published
- 2017
- Full Text
- View/download PDF